No abstract available
MeSH terms
-
Adult
-
Age Factors
-
COVID-19
-
Cause of Death
-
China
-
Comorbidity
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / prevention & control*
-
Female
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hyperlipoproteinemia Type II / diagnosis
-
Hyperlipoproteinemia Type II / drug therapy*
-
Hyperlipoproteinemia Type II / epidemiology*
-
Incidence
-
Male
-
Middle Aged
-
Pandemics / prevention & control*
-
Pandemics / statistics & numerical data
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / prevention & control*
-
Prognosis
-
Proprotein Convertase 9 / drug effects*
-
Proprotein Convertase 9 / genetics
-
Proprotein Convertase 9 / therapeutic use
-
Risk Assessment
-
Sex Factors
-
Survival Analysis
-
Treatment Outcome
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
PCSK9 protein, human
-
Proprotein Convertase 9